H1B Salary Data

Home › Employers › Clinical Trial Media Inc.

Clinical Trial Media Inc.: H-1B salaries and sponsorship

Clinical Trial Media Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $136,500.

Applications (LCAs)4
Certified4
Employer addressHauppauge, NY
Median offered salary$136,500
Middle half of salaries$126,500–$149,875
10th–90th percentile$126,500–$155,950

Does Clinical Trial Media Inc. sponsor H-1B visas?

Clinical Trial Media Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Dec 2, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Marketing Manager2$126,500
Project Director2$153,250

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$126,500
FY20242$136,500
FY20261$160,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Project Director$160,000
E-3 · Level IV
West Palm Beach, FLDec 2, 2025Jan 10, 2026Certified
Project Director$146,500
E-3 · Level IV
Delray Beach, FLJan 5, 2024Jan 10, 2024Certified
Marketing Manager$126,500
E-3 · Level I
Delray Beach, FLDec 7, 2023Mar 22, 2024Certified, then withdrawn
Marketing Manager$126,500
E-3 · Level I
Delray Beach, FLSep 18, 2023Sep 18, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).